Vanguard Group Portfolio holdings
Vanguard Group is an investment manager owned by the funds it manages, and so by its own customers. John Bogle founded it in 1975 and is credited with creating the first index fund available to individual investors. After Wellington Management fired Bogle in 1974, he started a new fund division there and named it Vanguard after HMS Vanguard, Horatio Nelson's flagship. Bogle set up its first index fund in 1976, the fund that became the Vanguard 500 Index Fund, and the firm added a bond index fund in 1986. It began offering ETFs in 2001 as exchange-traded shares of its index funds, and it also serves employers' retirement plans and independent financial advisers. Salim Ramji, who came from BlackRock, was named chief executive in 2024 as the first outsider to lead the firm.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$8.03B |
| 2 |
Microsoft
MSFT
|
+$8B |
| 3 |
Apple
AAPL
|
+$7.21B |
| 4 |
TotalEnergies
TTE
|
+$5.18B |
| 5 |
Meta Platforms (Facebook)
META
|
+$4.85B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Kellanova
K
|
+$2.74B |
| 2 |
DuPont de Nemours
DD
|
+$2.65B |
| 3 |
Mr. Cooper
COOP
|
+$1.41B |
| 4 |
Interpublic Group of Companies
IPG
|
+$1.24B |
| 5 |
Amazon
AMZN
|
+$1.13B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 32% |
| 2 | Financials | 13.5% |
| 3 | Consumer Discretionary | 9.9% |
| 4 | Healthcare | 9.82% |
| 5 | Communication Services | 9.03% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
3601
Rafael Holdings
RFL
$55.8M
| $1.76M | ﹤0.01% |
1,493,277
+98,551
| +7% | +$128K |
2018 Q1
31 quarters
|
|
3602
Fuel Tech
FTEK
$40.9M
| $1.76M | ﹤0.01% |
1,126,003
+112,139
| +11% | +$247K |
2013 Q2
50 quarters
|
|
3603
TuHURA Biosciences
HURA
$88.6M
| $1.76M | ﹤0.01% |
2,319,762
+50,096
| +2% | +$95.9K |
2023 Q3
9 quarters
|
|
3604
Enerflex
EFXT
$2.47B
| $1.75M | ﹤0.01% |
113,473
| – | – |
2022 Q4
12 quarters
|
|
3605
Cellebrite
CLBT
$2.9B
| $1.74M | ﹤0.01% |
96,394
-7,264
| -7% | -$130K |
2021 Q4
16 quarters
|
|
3606
Vanguard S&P Mid-Cap 400 ETF
IVOO
$3.86B
| $1.74M | ﹤0.01% |
15,523
+53
| +0.3% | +$5.88K |
2023 Q1
11 quarters
|
|
3607
Star Equity Holdings
STRR
$36.9M
| $1.73M | ﹤0.01% |
153,630
+4,612
| +3% | +$49.4K |
2013 Q2
50 quarters
|
|
3608
Dominari Holdings
DOMH
$18.6M
| $1.71M | ﹤0.01% |
345,896
| – | – |
2019 Q2
26 quarters
|
|
3609
Mobile Infrastructure Corp
BEEP
$96.6M
| $1.71M | ﹤0.01% |
670,012
+76,952
| +13% | +$241K |
2024 Q1
7 quarters
|
|
3610
iBio
IBIO
$51.6M
| $1.7M | ﹤0.01% |
883,149
+609,079
| +222% | +$831K |
2024 Q2
6 quarters
|
|
3611
Schwab US Broad Market ETF
SCHB
$44.2B
| $1.7M | ﹤0.01% |
64,910
+1,704
| +3% | +$44.4K |
2023 Q4
8 quarters
|
|
3612
Odyssey Marine Exploration
OMEX
$23.5M
| $1.7M | ﹤0.01% |
34,743
+9,128
| +36% | +$528K |
2013 Q2
50 quarters
|
|
3613
Magyar Bancorp
MGYR
$142M
| $1.69M | ﹤0.01% |
96,279
-4,438
| -4% | -$75.5K |
2013 Q2
50 quarters
|
|
3614
Acrivon Therapeutics
ACRV
$62.1M
| $1.68M | ﹤0.01% |
698,857
+72,709
| +12% | +$158K |
2023 Q1
11 quarters
|
|
3615
Schwab US Large- Cap ETF
SCHX
$73.2B
| $1.68M | ﹤0.01% |
62,486
+18,168
| +41% | +$485K |
2023 Q4
8 quarters
|
|
3616
Solesence Inc
SLSN
$107M
| $1.67M | ﹤0.01% |
1,048,394
+5,678
| +0.5% | +$15.4K |
2025 Q2
2 quarters
|
|
3617
Bogota Financial
BSBK
$120M
| $1.67M | ﹤0.01% |
196,945
+8,337
| +4% | +$71.3K |
2020 Q2
22 quarters
|
|
3618
Beneficient
BENF
$9.7M
| $1.67M | ﹤0.01% |
237,129
+235,582
| +15,228% | +$1.29M |
2023 Q3
9 quarters
|
|
3619
Vizsla Silver
VZLA
$1.09B
| $1.66M | ﹤0.01% |
302,308
| – | – |
2025 Q3
1 quarter
|
|
3620
Braskem
BAK
$450M
| $1.65M | ﹤0.01% |
560,466
| – | – |
2019 Q4
24 quarters
|
|
3621
OptimumBank Holdings
OPHC
$114M
| $1.65M | ﹤0.01% |
387,733
+1,910
| +0.5% | +$7.88K |
2021 Q1
19 quarters
|
|
3622
ImageneBio Inc
IMA
$43.2M
| $1.64M | ﹤0.01% |
238,000
+4,642
| +2% | +$34.4K |
2021 Q1
19 quarters
|
|
3623
Mercer International
MERC
$16.1M
| $1.64M | ﹤0.01% |
828,440
-1,636
| -0.2% | -$3.45K |
2013 Q2
50 quarters
|
|
3624
Cumberland Pharmaceuticals
CPIX
$88.2M
| $1.64M | ﹤0.01% |
411,786
| – | – |
2013 Q2
50 quarters
|
|
3625
Silvaco Group
SVCO
$244M
| $1.64M | ﹤0.01% |
404,310
+2,661
| +0.7% | +$13.2K |
2024 Q2
6 quarters
|
|
Similar funds
Vanguard Group's Q4 2025 Portfolio in Review
As of Q4 2025, Vanguard Group held 4,426 positions worth $6.9T, up 3.3% from $6.68T the previous quarter. Its ten largest holdings account for 31% of the portfolio.
Trading was light in Q4 2025: portfolio turnover was 4.1%. Vanguard Group opened 82 new positions and exited 98, leaving the 4,426-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 32% of assets, down from 32% a quarter earlier, followed by Financials and Consumer Discretionary.
- Vanguard Group's largest Q4 2025 buy was TotalEnergies: 81,863,403 shares worth $5.34B.
- Vanguard Group added most to NVIDIA in Q4 2025, an estimated $8.03B increase.
- Vanguard Group's biggest Q4 2025 reduction was DuPont de Nemours, cutting an estimated $2.65B.
- Vanguard Group fully exited Kellanova in Q4 2025, selling an estimated $2.74B.
- Vanguard Group's ten largest holdings make up 31% of its $6.9T portfolio in Q4 2025.
- Vanguard Group opened 82 new positions and closed 98 in Q4 2025.
- Vanguard Group's portfolio value rose 3.3% quarter-over-quarter to $6.9T.
Based on Vanguard Group's 13F filing for Q4 2025, filed 29 Jan 2026.